Article metrics

Download PDFPDF
Safety and tolerability of subcutaneous trastuzumab and intravenous pertuzumab as adjuvant treatment for HER2 positive breast cancer: a pilot study

 

Online download statistics by month:

Online download statistics by month: May 2021 to September 2021

AbstractFullPdf
May 2021642
Jun 202114136
Jul 20211063
Aug 2021542
Sep 2021433
Total393016